95 related articles for article (PubMed ID: 12481238)
1. [Granulocytic sarcoma of the tonsils associated with myelodysplastic syndrome].
Geisse M; Mall G; Fritze D; Gartenschläger M
Dtsch Med Wochenschr; 2002 Dec; 127(50):2673-6. PubMed ID: 12481238
[TBL] [Abstract][Full Text] [Related]
2. A cytochemical note on nucleoli of granulocytic precursors and granulocytes in patients suffering from the refractory anemia with excess blasts (RAEB) of the myelodysplastic syndrome (MDS).
Smetana K; Jirásková I; Malasková V; Cermák J
Neoplasma; 2002; 49(1):5-9. PubMed ID: 12044061
[TBL] [Abstract][Full Text] [Related]
3. Trilineage extramedullary myeloid cell tumor in myelodysplastic syndrome.
Hancock JC; Prchal JT; Bennett JM; Listinsky CM
Arch Pathol Lab Med; 1997 May; 121(5):520-3. PubMed ID: 9167610
[TBL] [Abstract][Full Text] [Related]
4. A specific cutaneous lesion revealing myelodysplastic syndrome.
Kajisawa C; Matsui C; Morohashi M
Eur J Dermatol; 1998; 8(7):517-8. PubMed ID: 9854168
[TBL] [Abstract][Full Text] [Related]
5. Myeloid Sarcoma of the Bladder in the Setting of Refractory Anemia with Excess Blasts-2 (RAEB-2).
Grantham JT; Howell DM; Bacaj PJ; Coad JE; Vos JA
W V Med J; 2015; 111(6):34-6. PubMed ID: 26665895
[TBL] [Abstract][Full Text] [Related]
6. Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB).
Omine M; Yamauchi H
Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):800-10. PubMed ID: 2618556
[TBL] [Abstract][Full Text] [Related]
7. The myelodysplastic syndromes. Part I. What are they? Part II. Classification.
Galton DA
Scand J Haematol Suppl; 1986; 45():11-20. PubMed ID: 3515515
[No Abstract] [Full Text] [Related]
8. Copper deficiency with increased hematogones mimicking refractory anemia with excess blasts.
Koca E; Buyukasik Y; Cetiner D; Yilmaz R; Sayinalp N; Yasavul U; Uner A
Leuk Res; 2008 Mar; 32(3):495-9. PubMed ID: 17706281
[TBL] [Abstract][Full Text] [Related]
9. A case of monocytic leukaemia cutis in a patient with myelodysplastic syndrome transforming to acute myeloid leukaemia.
Perez A; Kennedy C; Standen G; Oxley J
Clin Exp Dermatol; 2004 Sep; 29(5):497-8. PubMed ID: 15347335
[TBL] [Abstract][Full Text] [Related]
10. Squamous cell carcinoma of the tonsil masquerading as a peritonsillar abscess.
Fort MM; Gathings R; Domanski MC
Am J Emerg Med; 2013 Jun; 31(6):1002.e3-4. PubMed ID: 23669066
[TBL] [Abstract][Full Text] [Related]
11. Myelodysplastic syndrome: a review from University Hospital, Kuala Lumpur.
Ng SC; Kuperan P; Bosco J; Menaka N
Singapore Med J; 1990 Apr; 31(2):153-8. PubMed ID: 2196685
[TBL] [Abstract][Full Text] [Related]
12. [Sweet's syndrome associated with myelodysplastic syndrome].
Furukawa Y; Inoue T; Yamane T; Hiyoshi M; Sasaki A; Kishida T; Kojima K; Im T; Tatsumi N
Rinsho Ketsueki; 1989 May; 30(5):764-7. PubMed ID: 2795888
[TBL] [Abstract][Full Text] [Related]
13. [Refractory anemia showing excess of blasts (BAEB) that transformed into acute myelogenous leukemia (AML-M2) with a t (?8;20) chromosomal abnormality].
Maekawa T; Fujii H; Shizumi Y; Ebisui S; Horishi M; Suyama Y; Miyoshi M; Horiike S
Gan No Rinsho; 1988 Dec; 34(15):2109-13. PubMed ID: 3230641
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporin A in myelodysplastic syndrome: a preliminary report.
Dixit A; Chatterjee T; Mishra P; Choudhary DR; Mahapatra M; Saxena R; Choudhry VP
Ann Hematol; 2005 Sep; 84(9):565-8. PubMed ID: 15809884
[TBL] [Abstract][Full Text] [Related]
15. Classification of the myelodysplastic syndromes.
Bennett JM
Clin Haematol; 1986 Nov; 15(4):909-23. PubMed ID: 3471370
[No Abstract] [Full Text] [Related]
16. [Appearance of Sweet's syndrome in a patient with myelodysplastic syndrome (MDS) without relation to the hematological findings of MDS].
Hasegawa Y; Tomiyama J; Ninomiya H; Abe T
Rinsho Ketsueki; 1989 Jun; 30(6):863-7. PubMed ID: 2795896
[TBL] [Abstract][Full Text] [Related]
17. [Refractory anemia with excess of blasts (RAEB) with a high level of HbF that preceded apparent pancytopenia].
Matsuda A; Kusumoto S; Ito K; Yokoo H; Maruyama T; Jinnai I; Harano T; Watanabe K; Hirashima K
Rinsho Ketsueki; 1996 Jan; 37(1):60-4. PubMed ID: 8683869
[TBL] [Abstract][Full Text] [Related]
18. Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia.
Estey EH; Keating MJ; Dixon DO; Trujillo JM; McCredie KB; Freireich EJ
Hematol Pathol; 1987; 1(4):203-8. PubMed ID: 3504436
[TBL] [Abstract][Full Text] [Related]
19. [Successful treatment of refractory anemia with excess of blasts in transformation with cytarabine ocfosfate].
Takeuchi M; Kojima K; Takaba S; Isokawa M; Tanimizu M; Kimura F; Ohmoto E; Harada M
Gan To Kagaku Ryoho; 1995 Jan; 22(1):141-4. PubMed ID: 7826071
[TBL] [Abstract][Full Text] [Related]
20. Proposals for the classification of the myelodysplastic syndromes.
Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick HR; Sultan C
Br J Haematol; 1982 Jun; 51(2):189-99. PubMed ID: 6952920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
